TPBG
LMAT icon

Turning Point Benefit Group’s LeMaitre Vascular LMAT Stock Holding History

Turning Point Benefit Group’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$162 – 488
2025
Q4 		$162 Hold
2
– – ﹤0.01% 778
2025
Q3 		$173 Buy
+2
New +$179 ﹤0.01% 670

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Turning Point Benefit Group's LMAT Position: Q1 2026 in Review

Turning Point Benefit Group sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 2 shares — an estimated $162 sold.

Turning Point Benefit Group first reported a position in LMAT in Q3 2025 and held it in 2 quarters. The position peaked at $173 in Q3 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Turning Point Benefit Group reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
  • Turning Point Benefit Group sold 2 LeMaitre Vascular shares in Q1 2026, an estimated $162.
  • Turning Point Benefit Group first reported a position in LeMaitre Vascular in Q3 2025 and held it in 2 quarters.
  • Turning Point Benefit Group's LeMaitre Vascular position peaked at $173 in Q3 2025.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.